AR and lung cancer: Surprisingly, in AR/TMPRSS2 double-positive H2126 and H1437 lung cancer cells, neither AR inhibition using enzalutamide nor AR stimulation using DHT resulted in a significant change in TMPRSS2 expression, implying that AR cannot regulate TMPRSS2 expression in human lung cancer cells.